Advisors Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Buy |
1,326
+55
| +4% | +$24.5K | 0.01% | 345 |
|
|
2025
Q1 | $616K | Sell |
1,271
-12,975
| -91% | -$6.29M | 0.01% | 335 |
|
|
2024
Q4 | $5.74M | Sell |
14,246
-295
| -2% | -$119K | 0.09% | 182 |
|
|
2024
Q3 | $6.76M | Buy |
14,541
+860
| +6% | +$400K | 0.11% | 167 |
|
|
2024
Q2 | $6.41M | Sell |
13,681
-45
| -0.3% | -$21.1K | 0.11% | 169 |
|
|
2024
Q1 | $5.74M | Sell |
13,726
-2,329
| -15% | -$974K | 0.11% | 173 |
|
|
2023
Q4 | $6.53M | Buy |
16,055
+2,754
| +21% | +$1.12M | 0.13% | 153 |
|
|
2023
Q3 | $4.63M | Buy |
+13,301
| New | +$4.63M | 0.12% | 162 |
|